ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,711,000 | -80.0% | 361,722 | -84.9% | 0.09% | -80.4% |
| Q3 2014 | $8,537,000 | -10.7% | 2,391,200 | +14.1% | 0.44% | -15.1% |
| Q2 2014 | $9,559,000 | -9.9% | 2,096,200 | -7.1% | 0.52% | -14.8% |
| Q1 2014 | $10,604,000 | -19.6% | 2,256,200 | -14.3% | 0.61% | -21.6% |
| Q4 2013 | $13,194,000 | -26.3% | 2,633,600 | -8.5% | 0.77% | -36.5% |
| Q3 2013 | $17,905,000 | +14.7% | 2,878,600 | -16.3% | 1.22% | +16.2% |
| Q2 2013 | $15,605,000 | – | 3,437,293 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |